Mackenzie Financial’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $175M | Sell |
|
|||||
2025
Q1 | $208M | Sell |
|
|||||
2024
Q4 | $212M | Buy |
|
|||||
2024
Q3 | $238M | Sell |
|
|||||
2024
Q2 | $253M | Sell |
|
|||||
2024
Q1 | $219M | Sell |
|
|||||
2023
Q4 | $172M | Sell |
|
|||||
2023
Q3 | $178M | Buy |
|
|||||
2023
Q2 | $149M | Buy |
|
|||||
2023
Q1 | $92.8M | Buy |
|
|||||
2022
Q4 | $97.8M | Buy |
|
|||||
2022
Q3 | $83.7M | Buy |
|
|||||
2022
Q2 | $79.1M | Buy |
|
|||||
2022
Q1 | $50.4M | Sell |
|
|||||
2021
Q4 | $56.4M | Sell |
|
|||||
2021
Q3 | $55.8M | Sell |
|
|||||
2021
Q2 | $60.8M | Sell |
|
|||||
2021
Q1 | $54.2M | Buy |
|
|||||
2020
Q4 | $47.5M | Buy |
|
|||||
2020
Q3 | $39.9M | Buy |
|
|||||
2020
Q2 | $39.7M | Buy |
|
|||||
2020
Q1 | $19.8M | Sell |
|
|||||
2019
Q4 | $19.5M | Buy |
|
|||||
2019
Q3 | $10M | Buy |
|
|||||
2019
Q2 | $9.37M | Sell |
|
|||||
2019
Q1 | $14.8M | Sell |
|
|||||
2018
Q4 | $15.3M | Buy |
|
|||||
2018
Q3 | $5.78M | Buy |
|
|||||
2018
Q2 | $3.73M | Buy |
|
|||||
2018
Q1 | $2.34M | Buy |
|
|||||
2017
Q4 | $1.06M | Buy |
|
|||||
2016
Q3 | – | Sell |
|
|||||
2016
Q2 | $5.02M | Buy |
|
|||||
2016
Q1 | $4.18M | Sell |
|
|||||
2015
Q4 | $6.49M | Buy |
|
|||||
2015
Q3 | $5.91M | Buy |
|
|||||
2015
Q2 | $3.53M | Buy |
|
|||||
2015
Q1 | $2.87M | Buy |
|
|||||
2014
Q4 | $2.45M | Sell |
|
|||||
2014
Q3 | $3.05M | Buy |
|
|||||
2014
Q2 | $1.01M | Buy |
|
|||||
2014
Q1 | $790K | Sell |
|
|||||
2013
Q4 | $729K | Buy |
|
|||||
2013
Q3 | $535K | Buy |
|
|||||
2013
Q2 | $492K | Buy |
|